Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company focused on developing life-saving therapies, announced a significant breakthrough with the United Kingdom (U.K.) Medicines and Healthcare products Regulatory Agency (MHRA) approving REZZAYO (rezafungin acetate) for invasive candidiasis treatment in adults. This announcement is a major advancement in healthcare, addressing a critical need for new treatments in […]
Mundipharma, a German pharmaceutical company, has achieved a significant milestone with the European Commission (EC)’s approval of Pelmeg, its pegylated biosimilar to Amgen’s Neulasta (pegfilgrastim). Designed to reduce the duration of neutropenia and associated infections in adults undergoing chemotherapy, Pelmeg provides a cost-effective alternative to traditional treatment options. EU Approval of Pelmeg for Neutropenia The […]
